AAVATAR Therapeutics is dedicated to advancing human health 

through gene therapy based on the core value of true life respect.


As a research-driven biotech company, we uphold human dignity in 

all business activities and pursue sustainable growth through responsible 

engagement with employees, customers, partners, and the broader community.


This Human Rights Charter serves as a key pillar of our ESG management and guides 

our commitment to protecting human rights and fulfilling our corporate social responsibilities.


Human Rights Code of Conduct


  [Human Rights for Customers] 

  • We protect customer privacy and life-related data with the utmost care, and provide ethical and transparent treatment solutions.

  • We respect customer feedback and pursue patient-centered innovation based on scientific evidence and personalized medicine. 


  [Human Rights for Business Partners]

  • We maintain fair and transparent partnerships and promote human rights-based, sustainable collaborations.
  • We work together with partners to foster mutual respect, social value, and shared growth.


  [Community and Local Human Rights ]

  • We contribute to regional biotech ecosystems by supporting local education and talent development. 
  • We actively participate in public healthcare initiatives and community engagement to promote well-being. 


  [Employee Human Rights]

  • We provide a safe and respectful workplace where diversity, equality, and labor rights are protected.
  • We foster a corporate culture where dignity, inclusion, and work-life balance are fully upheld.


  [Human Rights in Research & Development]

  • In all stages of research—including preclinical, clinical, and non-clinical—we prioritize ethical conduct and human dignity.
  • Our R&D practices comply with international ethical standards and scientific guidelines for safety, efficacy, and transparency.


  [Human Rights in Manufacturing & Product Quality ]

  • We deliver high-quality treatments through GMP-compliant production and strict safety protocols.
  • All manufacturing processes reflect our commitment to ethical responsibility and regulatory compliance.

Statement on Human Rights  


  ONE,  We respect and comply with international human rights standards
             including the Universal Declaration of Human Rights and relevant national human rights regulations. 

 

  ONE, We do not discriminate against any stakeholder
            on the basis of race, religion, disability, gender, birth, political opinion, or social status. 

 

  ONE, We respect the rights of workers to freedom of association and collective bargaining
            and strictly prohibit all forms of forced labor and child labor. 

 

  ONE, We promote a safe and healthy working environment
            by preventing workplace hazards and protecting employee well-being. 

 

  ONE, We safeguard the safety and privacy of our employees and customers
            by preventing infringement and managing personal data responsibly. 

 

  ONE, We build sustainable partnerships

            based on mutual respect and human rights with all suppliers, contractors, and stakeholders.

 

  ONE , We respect and contribute to the rights of local communities
             where we operate, including initiatives that promote public health and social inclusion. 

 

  ONE ,  We comply with Korean environmental laws and global sustainability standards
              and implement ESG practices through transparent governance. 

 

  ONE,  We ensure transparency in business operations
             and protect confidential information and stakeholder trust. 

 

  ONE , We provide accessible grievance mechanisms
             to address any adverse human rights impacts and take prompt remedial action. 


Innovation in gene therapy, changing the lives of patients with rare and incurable diseases.


We are with you through the entire process of rare disease treatment, from the development of AAV platform technology to the production of customized treatments.



MON — FRI (8 AM ~ 5 PM)

TEL  |  070-4229-0321

EMAIL  |  information@aavatartps.com




COMPANY  |  AAVATAR Therapeutics

CEO  |  Seunghee Cho

BUSINESS NUMBER  |  235-81-02296


HQ

Unit 1023, Building B, 540 Misa-daero,

Hanam-si, Gyeonggi-do, Republic of Korea


BioHub

Room 203, R&D Center, Seoul Bio Hub, 117-3,

Hoegi-ro, Dongdaemun-gu, Seoul, Republic of Korea


Copyright ⓒ 2025 AAVATAR Therapeutics All rights reserved.

Innovation in gene therapy, changing the lives of patients with rare and incurable diseases.



We are with you through the entire process of rare disease treatment, from the development of AAV platform technology to the production of customized treatments.

MON — FRI (8 AM ~ 5 PM)

TEL  |  070-4229-0321

EMAIL  |  information@aavatartps.com


COMPANY  |  AAVATAR Therapeutics    CEO  |  Seunghee Cho      BUSINESS NUMBER  |  235-81-02296

HQ  |  Unit 1023, Building B, 540 Misa-daero, Hanam-si, Gyeonggi-do, Republic of Korea

BioHub  |  Room 203, R&D Center, Seoul Bio Hub, 117-3, Hoegi-ro, Dongdaemun-gu, Seoul, Republic of Korea


Copyright ⓒ 2025 AAVATAR Therapeutics All rights reserved. |  SITE BY. DOTCLE